MR susceptibility weighted imaging (SWI) complements conventional contrast enhanced T1 weighted MRI in characterizing brain abnormalities of Sturge-Weber syndrome

Journal of Magnetic Resonance Imaging

Volumn 28, Issue 2, 2008, Pages 300-307

  Hu, Jiani ^a   Yu, Yingjian ^b   Juhasz, Csaba ^a,c   Kou, Zhifeng ^a,b   Xuan, Yang ^a   Latif, Zahid ^a   Kudo, Kohsuke ^a   Chugani, Harry T ^a,c   Haacke, E Mark ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b MRI Institute for Biomedical Research   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contrast enhanced T1 weighted imaging; Magnetic resonance; Magnetic resonance imaging; Sturge Weber syndrome; Susceptibility weighted imaging; T1 gadolinium

Indexed keywords

GADOLINIUM PENTETATE;

ADOLESCENT; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN DISEASE; BRAIN JUNCTION ABNORMALITY; BRAIN VEIN; BRAIN VENTRICLE; CHILD; CHOROID PLEXUS; CHOROID PLEXUS ENLARGEMENT; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORTICAL GYRIFORM ABNORMALITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; GRAY MATTER; HEMISPHERE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LEPTOMENINGEAL ABNORMALITY; LEPTOMENINX; MALE; MEDICAL INFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; STURGE WEBER SYNDROME; SUSCEPTIBILITY WEIGHTED IMAGING; THREE DIMENSIONAL IMAGING; TRANSMEDULLARY VEIN ENLARGEMENT; WHITE MATTER;

BRAIN; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDIES; STURGE-WEBER SYNDROME;

EID: 49049115314     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21435     Document Type: Article

References (39)

1. Lee JS, Asano E, Muzik O, et al. Sturge-Weber syndrome: correlation between clinical course and FDG PET findings. Neurology 2001;57:189-195.
2. Fischbein NJ, Barkovich AJ, Wu Y, Berg BO. Sturge-Weber syndrome with no leptomeningeal enhancement on MRI. Neuroradiology 1998;40:177-180.
3. Reid DE, Maria BL, Drane WE, Quisling RG, Hoang KB. CNS perfusion and metabolism abnormalities in Sturge-Weber syndrome. J Child Neurol 1997;12:218-222.
4. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Res Med 2004;52:612-618.
5. Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204:272-279.
6. Wang Y, Yu Y, Li D, et al. Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging 2000;12:661-670.
7. Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005;22:439-450.
8. Mentzel HJ, Dieckmann A, Fitzek C, Brandi U, Reichenbach JR, Kaiser WA. Early diagnosis of cerebral involvement in Sturge-Weber syndrome using high-resolution BOLD MR venography. Pediatr Radiol 2005;35:85-90.
9. Tan IL, van Schijndel RA, Pouwels PJW, et al. MR Venography of Multiple Sclerosis. AJNR Am J Neuroradiol 2000;21:1039-1042.
10. Tong KA, Ashwal S, Holshouser BA, et al. Detection of hemorrhage in children with diffuse axonal injury. Radiology 2003;227:332-339.
11. Tong KA, Ashwal S, Holshouser BA, et al. Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol 2004;56:36-50.
12. Shen Y, Kou Z, Kreipkec CW, Petrovc T, Hu J, Haacke EM. In vivo measurement of tissue damage, oxygen saturation changes and blood flow changes after experimental traumatic brain injury in rats using susceptibility weighted imaging. Magn Reson Imaging 2007;25:219-227.
13. Sehgal V, Delproposto Z, Haddar D, et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 2006;24:41-51.
14. Juhász C, Haacke M, Hu J, et al. Multimodality imaging of cortical and white matter abnormalities in Sturge-Weber syndrome. AJNR Am J Neuroradiol 2007;28:900-906.
15. Xu Y, Haacke EM. The role of voxel aspect ratio in determining apparent vascular phase behavior in susceptibility weighted imaging. Magn Reson Imaging 2006;24:155-160.
16. Thomas-Sohl KA, Vaslow DF, Maria BL. Sturge-Weber syndrome: a review. Pediatr Neurol 2004;30:303-310.
17. Baselga E. Sturge-Weber syndrome. Semin Cutan Med Surg 2004;23:87-98.
18. Aicardi J, Arzimanoglou A. Sturge-Weber syndrome. Int Pediatr 1991;6:129-134.
19. Bentson JR, Wilson GH, Newton T. Cerebral venous drainage pattern of the Sturge-Weber syndrome. Radiology 1971;101:111-118.
20. Vogl TJ, Stemmler J, Bergman C, Pflugger T, Egger E, Lissner J. MR and MR angiography in Sturge-Weber syndrome. AJNR Am J Neuroradiol 1993;14:417-425.
21. Coley SC, Britton J, Clarke A. Status epilepticus and venous infarctionin Sturge-Weber syndrome. Childs Nerv Syst 1998;14:693-696.
22. Okudaira Y, Arai H, Sato K. Hemodynamic compromise as a factor in clinical progression of Sturge-Weber syndrome. Childs Nerv Syst 1997;13:214-219.
23. Sugama S, Yoshimura H, Ashimine K, Eto Y, Maekawa K. Enhanced magnetic resonance imaging of leptomeningeal angiomatosis. Pediatr Neurol 1997;17:262-265.
24. Mandelstam S, Andronikou S. MRI evaluation of venous abnormalities in children with Sturge-Weber syndrome. J Pediatr Neurol 2004;2:29-32.
25. Benedikt RA, Brown DC, Walker R, et al. Sturge-Weber syndrome: cranial MR imaging with Gd-DTPA. AJNR Am J Neuroradiol 1993;14:409-415.
26. Cure JK, Holden KR, van Tassel P. Progressive venous occlusion in a neonate with Sturge-Weber syndrome: demonstration with MR venography. AJNR Am J Neuroradiol 1995;16:1539-1542.
27. Juhász C, Haacke EM, Hu J, et al. Multimodality imaging of cortical and white matter abnormalities in Sturge-Weber syndrome. AJNR Am J Neuroradiol 2007;28:900-906.
28. Welch K, Naheedy MH, Abroms IF, Strand RD. Computed tomography of Sturge-Weber syndrome. J Comput Assist Tomogr 1980;4:33-36.
29. Bodensteiner JB, Roach ES. Sturge-Weber syndrome: introduction and overview. In: Bodensteiner JB, Roach ES, editors. Sturge-Weber syndrome. Mt. Freedom, NJ: Sturge-Weber Foundation; 1999. p 1-10.
30. Norman MG, Schoene WC. The ultrastructure of Sturge-Weber disease. Acta Neuropathol 1977;37:199-205.
31. Di Trapani G, Di Rocco C, Abbamondi AL, Caldarelli M, Pocchiari M. Light microscopy and ultrastructural studies of Sturge-Weber disease. Childs Brain 1982;9:23-36.
32. Dimitri V. Tumor cerebral congenito (angioma cavernoso). Rev Assoc Med Argent 1923;36:1029-1037.
33. Griffiths PD, Boodram MB, Blaser S, Armstrong D, Gilday DL, Harwood-Nash D. 99mTechnetium HMPAO imaging in children with the Sturge-Weber syndrome: a study of nine cases with CT and MRI correlation. Neuroradiology 1997;39:219-224.
34. Lin DD, Barker PB, Hatfield LA, Comi AM. Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms. J Magn Reson Imaging 2006;24:274-281.
35. Evans AL, Widjaja E, Connolly DJ, Griffiths PD. Cerebral perfusion abnormalities in children with Sturge-Weber syndrome shown by dynamic contrast bolus magnetic resonance perfusion imaging. Pediatrics 2006;117:2119-2125.
36. Guseo A. Ultrastructure of calcification in Sturge-Weber disease. Virchows Arch A Pathol Anat Histol 1975;366:353-356.
37. Elster AD, Chen MY. MR imaging of Sturge-Weber syndrome: role of gadopentetae dimeglumine and gradient-echo techniques. AJNR Am J Neuroradiol 1990;11:685-689.
38. Wohlwill FJ, Yakovlev PI. Histoptahology of meningo-facial angiomatosis (Sturge-Weber's disease). Neuropathol Exp Neurol 1957;16:341-364.
39. Nelson JS. The neuropathology of selected neurocutaneous diseases. Semin Pediatr Neurol 1995;2:192-199.